Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Hepatocellular | 2 | 2024 | 130 | 1.570 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 164 | 1.520 |
Why?
|
| Neoplasms | 4 | 2022 | 750 | 1.490 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2022 | 276 | 1.410 |
Why?
|
| Lipogenesis | 3 | 2022 | 29 | 1.090 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 4 | 2022 | 17 | 0.990 |
Why?
|
| Membrane Proteins | 3 | 2018 | 466 | 0.940 |
Why?
|
| Herpesvirus 1, Cercopithecine | 1 | 2022 | 1 | 0.810 |
Why?
|
| Hepatitis B, Chronic | 1 | 2022 | 6 | 0.810 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2022 | 23 | 0.790 |
Why?
|
| Antirheumatic Agents | 1 | 2022 | 56 | 0.770 |
Why?
|
| Immunotherapy | 1 | 2022 | 134 | 0.720 |
Why?
|
| Lipid Metabolism | 3 | 2018 | 118 | 0.640 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 115 | 0.520 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 656 | 0.500 |
Why?
|
| Protein Tyrosine Phosphatases | 3 | 2022 | 37 | 0.460 |
Why?
|
| Glioblastoma | 3 | 2020 | 95 | 0.410 |
Why?
|
| p21-Activated Kinases | 2 | 2009 | 6 | 0.410 |
Why?
|
| Nuclear Proteins | 3 | 2022 | 245 | 0.400 |
Why?
|
| Humans | 17 | 2024 | 26838 | 0.380 |
Why?
|
| Nephrons | 2 | 2022 | 8 | 0.330 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2009 | 7 | 0.330 |
Why?
|
| Endoplasmic Reticulum | 3 | 2018 | 77 | 0.320 |
Why?
|
| Cell Movement | 2 | 2020 | 353 | 0.320 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 93 | 0.300 |
Why?
|
| Glucose | 2 | 2022 | 190 | 0.300 |
Why?
|
| Carrier Proteins | 1 | 2009 | 245 | 0.280 |
Why?
|
| Animals | 12 | 2022 | 9949 | 0.280 |
Why?
|
| Golgi Apparatus | 2 | 2016 | 26 | 0.270 |
Why?
|
| Glycosylation | 2 | 2016 | 69 | 0.270 |
Why?
|
| Mice, Nude | 5 | 2020 | 312 | 0.270 |
Why?
|
| Transcription Factors | 3 | 2016 | 511 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2016 | 40 | 0.260 |
Why?
|
| Polyamines | 1 | 2024 | 12 | 0.240 |
Why?
|
| Transplantation, Heterologous | 3 | 2022 | 60 | 0.230 |
Why?
|
| Protein Binding | 4 | 2016 | 631 | 0.230 |
Why?
|
| Insulin | 2 | 2022 | 309 | 0.220 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2022 | 2 | 0.210 |
Why?
|
| Islets of Langerhans | 1 | 2022 | 9 | 0.210 |
Why?
|
| Sterols | 1 | 2022 | 3 | 0.210 |
Why?
|
| Organ Transplantation | 1 | 2022 | 13 | 0.210 |
Why?
|
| Graft Rejection | 1 | 2022 | 33 | 0.200 |
Why?
|
| Ammonia | 1 | 2022 | 18 | 0.200 |
Why?
|
| Virus Activation | 1 | 2022 | 9 | 0.200 |
Why?
|
| Glutamine | 1 | 2022 | 32 | 0.200 |
Why?
|
| Hepatitis B virus | 1 | 2022 | 16 | 0.200 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2022 | 94 | 0.200 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 67 | 0.190 |
Why?
|
| Antiviral Agents | 1 | 2022 | 104 | 0.190 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2020 | 2 | 0.180 |
Why?
|
| Fats | 1 | 2020 | 6 | 0.180 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 144 | 0.180 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2020 | 1 | 0.180 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 106 | 0.170 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 82 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 439 | 0.170 |
Why?
|
| Cell Line | 3 | 2020 | 671 | 0.170 |
Why?
|
| Cholesterol | 2 | 2016 | 181 | 0.160 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2018 | 1 | 0.160 |
Why?
|
| DNA-Binding Proteins | 2 | 2022 | 482 | 0.150 |
Why?
|
| Cell Proliferation | 2 | 2020 | 766 | 0.140 |
Why?
|
| F-Box Proteins | 1 | 2016 | 10 | 0.140 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2016 | 1 | 0.140 |
Why?
|
| Mice | 5 | 2022 | 4401 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 69 | 0.130 |
Why?
|
| Protein Transport | 1 | 2016 | 152 | 0.130 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 1259 | 0.130 |
Why?
|
| ErbB Receptors | 1 | 2016 | 96 | 0.130 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 28 | 0.130 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 33 | 0.130 |
Why?
|
| Models, Biological | 1 | 2018 | 446 | 0.130 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 110 | 0.130 |
Why?
|
| RNA Interference | 1 | 2015 | 135 | 0.130 |
Why?
|
| Tumor Burden | 1 | 2015 | 108 | 0.130 |
Why?
|
| Cell Membrane | 1 | 2016 | 235 | 0.120 |
Why?
|
| HEK293 Cells | 1 | 2015 | 171 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2015 | 277 | 0.120 |
Why?
|
| Organogenesis | 1 | 2014 | 12 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 184 | 0.120 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 74 | 0.120 |
Why?
|
| Blotting, Western | 1 | 2015 | 503 | 0.110 |
Why?
|
| Stem Cells | 1 | 2014 | 113 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 563 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2016 | 155 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2016 | 278 | 0.100 |
Why?
|
| COS Cells | 2 | 2009 | 48 | 0.100 |
Why?
|
| Swine | 2 | 2022 | 220 | 0.100 |
Why?
|
| HeLa Cells | 2 | 2009 | 206 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 441 | 0.090 |
Why?
|
| Female | 5 | 2020 | 14455 | 0.090 |
Why?
|
| Dyneins | 1 | 2009 | 7 | 0.080 |
Why?
|
| Cyclins | 1 | 2009 | 8 | 0.080 |
Why?
|
| raf Kinases | 1 | 2009 | 1 | 0.080 |
Why?
|
| Pseudopodia | 1 | 2009 | 7 | 0.080 |
Why?
|
| Focal Adhesions | 1 | 2009 | 14 | 0.080 |
Why?
|
| NIH 3T3 Cells | 1 | 2009 | 44 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2009 | 57 | 0.080 |
Why?
|
| Muscle Proteins | 1 | 2009 | 50 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2009 | 117 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 68 | 0.080 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2009 | 43 | 0.080 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 80 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2009 | 262 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2009 | 135 | 0.080 |
Why?
|
| Glucagon | 1 | 2022 | 11 | 0.050 |
Why?
|
| Retroperitoneal Space | 1 | 2022 | 9 | 0.050 |
Why?
|
| Transcription Factors, General | 1 | 2022 | 1 | 0.050 |
Why?
|
| Co-Repressor Proteins | 1 | 2022 | 8 | 0.050 |
Why?
|
| Histone Deacetylases | 1 | 2022 | 22 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2022 | 23 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2022 | 48 | 0.050 |
Why?
|
| Heterografts | 1 | 2022 | 62 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2022 | 47 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2016 | 557 | 0.050 |
Why?
|
| Chromatin | 1 | 2022 | 73 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2022 | 50 | 0.050 |
Why?
|
| Proteomics | 1 | 2022 | 177 | 0.050 |
Why?
|
| Oncogenes | 1 | 2020 | 34 | 0.040 |
Why?
|
| Adenosine | 1 | 2020 | 33 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 180 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2020 | 79 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 151 | 0.040 |
Why?
|
| Rats | 1 | 2022 | 1536 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2009 | 67 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2020 | 645 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 674 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 1036 | 0.040 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2016 | 5 | 0.040 |
Why?
|
| Threonine | 1 | 2016 | 20 | 0.040 |
Why?
|
| Protein Stability | 1 | 2016 | 42 | 0.030 |
Why?
|
| Feedback | 1 | 2016 | 32 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2016 | 250 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2020 | 619 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 441 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 9 | 0.030 |
Why?
|
| Mesoderm | 1 | 2014 | 12 | 0.030 |
Why?
|
| Glioma | 1 | 2016 | 118 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 332 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 487 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 624 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2014 | 395 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 1925 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 1474 | 0.020 |
Why?
|
| Cyclin D3 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2009 | 3 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 10 | 0.020 |
Why?
|
| Myosin Type V | 1 | 2009 | 2 | 0.020 |
Why?
|
| Immobilized Proteins | 1 | 2009 | 9 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2009 | 58 | 0.020 |
Why?
|
| Molecular Mimicry | 1 | 2009 | 30 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2009 | 32 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 129 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 149 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 205 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 2582 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 2958 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 228 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 5162 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 6818 | 0.020 |
Why?
|
| Adult | 1 | 2016 | 7386 | 0.010 |
Why?
|
| Male | 1 | 2016 | 12859 | 0.010 |
Why?
|